We are live on ! Find out more
RG

Renaissance Group Portfolio holdings

AUM $2.39B
1-Year Est. Return 27.81%
This Fund
S&P 500
This Quarter Est. Return
+23.53%
1 Year Est. Return
+27.81%
3 Year Est. Return
+92.11%
5 Year Est. Return
+135.4%
10 Year Est. Return
+451.85%
AUM
$2.1B
AUM Growth
+$299M
Cap. Flow
-$102M
Cap. Flow %
-4.87%
Top 10 Hldgs %
15.85%
Holding
264
New
18
Increased
58
Reduced
158
Closed
28

Top Buys

Rank Stock Value
1
PG icon
Procter & Gamble
PG
+$24.3M
2
VRTX icon
Vertex Pharmaceuticals
VRTX
+$21.5M
3
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$18.7M
4
VIPS icon
Vipshop
VIPS
+$9.8M
5
AMZN icon
Amazon
AMZN
+$9.09M

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$24.8M
2
DIS icon
Walt Disney
DIS
+$19.1M
3
LUV icon
Southwest Airlines
LUV
+$17.8M
4
LH icon
Labcorp
LH
+$16.2M
5
SIVB
SVB Financial Group
SIVB
+$16.1M

Sector Composition

Rank Sector Weight
1 Technology 28.05%
2 Healthcare 14.11%
3 Industrials 12.02%
4 Financials 9.25%
5 Communication Services 8.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EHC icon
126
Encompass Health
EHC
$11.1B
$756K 0.04%
15,352
-109
-0.7% -$5.88K
EXLS icon
127
EXL Service
EXLS
$5.13B
$747K 0.04%
58,900
-80
-0.1% -$943
UI icon
128
Ubiquiti
UI
$34.4B
$740K 0.04%
4,238
-37
-0.9% -$6.21K
PRAH
129
DELISTED
PRA Health Sciences, Inc.
PRAH
$738K 0.04%
7,581
-65
-0.9% -$6.05K
GMED icon
130
Globus Medical
GMED
$10.9B
$730K 0.03%
15,297
+99
+0.7% +$4.78K
BEAT
131
DELISTED
BioTelemetry, Inc.
BEAT
$729K 0.03%
16,138
+143
+0.9% +$6.41K
FIX icon
132
Comfort Systems
FIX
$62.4B
$728K 0.03%
17,867
+164
+0.9% +$5.83K
MEDP icon
133
Medpace
MEDP
$16.3B
$723K 0.03%
7,775
-68
-0.9% -$5.79K
LOPE icon
134
Grand Canyon Education
LOPE
$3.93B
$716K 0.03%
7,908
+76
+1% +$6.76K
ADM icon
135
Archer Daniels Midland
ADM
$37.7B
$710K 0.03%
17,803
+2,011
+13% +$75.3K
PRFT
136
DELISTED
Perficient Inc
PRFT
$697K 0.03%
19,491
-25
-0.1% -$829
BIIB icon
137
Biogen
BIIB
$30.8B
$687K 0.03%
2,568
+245
+11% +$73.6K
NVEE
138
DELISTED
NV5 Global
NVEE
$683K 0.03%
53,752
+484
+0.9% +$5.45K
OMCL icon
139
Omnicell
OMCL
$1.7B
$679K 0.03%
9,613
-6
-0.1% -$411
EOG icon
140
EOG Resources
EOG
$71.8B
$678K 0.03%
13,392
+1,780
+15% +$86.3K
HQY icon
141
HealthEquity
HQY
$8.66B
$660K 0.03%
11,251
+99
+0.9% +$5.47K
SYF icon
142
Synchrony
SYF
$25.8B
$655K 0.03%
29,571
+4,972
+20% +$96.9K
RBC icon
143
RBC Bearings
RBC
$18.1B
$649K 0.03%
4,845
-4
-0.1% -$510
T icon
144
AT&T
T
$157B
$648K 0.03%
28,364
+3,690
+15% +$84K
TXRH icon
145
Texas Roadhouse
TXRH
$13.8B
$646K 0.03%
12,290
+100
+0.8% +$4.88K
COLL icon
146
Collegium Pharmaceutical
COLL
$1.17B
$639K 0.03%
36,521
+299
+0.8% +$5.85K
SYY icon
147
Sysco
SYY
$40.7B
$639K 0.03%
11,685
+1,545
+15% +$81.2K
KBH icon
148
KB Home
KBH
$3.62B
$635K 0.03%
20,693
+181
+0.9% +$4.98K
DOOR
149
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
$625K 0.03%
8,033
-3,508
-30% -$213K
HAE icon
150
Haemonetics
HAE
$3.84B
$614K 0.03%
6,857
+203
+3% +$20.5K
4 5
6
7 8

Similar funds

MAS
Meeder Advisory Services Dublin, Ohio $2.39B AUM 23.78% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return
HAG
HighPoint Advisor Group Downers Grove, Illinois $2.39B AUM 28.86% 1-Year Est. Return
CIP
Cornerstone Investment Partners Atlanta, Georgia $2.38B AUM 32.49% 1-Year Est. Return
BJL
Brighton Jones LLC Seattle, Washington $2.37B AUM 16.36% 1-Year Est. Return
PA
Paralel Advisors Denver, Colorado $2.41B AUM 9.57% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
SCA
STALEY CAPITAL ADVISERS Pittsburgh, Pennsylvania $2.36B AUM 23.72% 1-Year Est. Return

Renaissance Group's Q2 2020 Portfolio in Review

As of Q2 2020, Renaissance Group held 264 positions worth $2.1B, up 17% from $1.8B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Renaissance Group withdrew a net $102M in Q2 2020, closing 28 positions and reducing 158 holdings. Its most notable exit was Walt Disney, an estimated $19.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 27% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Renaissance Group opened a new position in Vertex Pharmaceuticals worth $23.1M.

  • Renaissance Group's largest Q2 2020 buy was Vertex Pharmaceuticals: 79,483 shares worth $23.1M.
  • Renaissance Group added most to Procter & Gamble in Q2 2020, an estimated $24.3M increase.
  • Renaissance Group's biggest Q2 2020 reduction was Gilead Sciences, cutting an estimated $24.8M.
  • Renaissance Group fully exited Walt Disney in Q2 2020, selling an estimated $19.1M.
  • Renaissance Group's ten largest holdings make up 16% of its $2.1B portfolio in Q2 2020.
  • Renaissance Group opened 18 new positions and closed 28 in Q2 2020.
  • Renaissance Group's portfolio value rose 17% quarter-over-quarter to $2.1B.

Based on Renaissance Group's 13F filing for Q2 2020, filed 12 Aug 2020.